CardioComm Solutions Provides AGM Update Regarding Canada Post Strike
CardioComm Solutions (TSXV: EKG, OTC: EKGGF), a medical ECG monitoring technology company, has announced alternative arrangements for accessing its Annual General Meeting (AGM) materials due to the ongoing Canada Post strike. The Meeting Materials for the December 11, 2024 AGM are available on SEDAR+ and the company's website.
Registered shareholders can contact the company directly at 1-877-977-9425 or via email for proxy assistance, with a voting deadline of 11:00 a.m. EST on December 9, 2024. Beneficial shareholders should contact their brokers for proxy requests. Paper copies of meeting materials can be requested until December 6, 2024.
CardioComm Solutions (TSXV: EKG, OTC: EKGGF), un'azienda di tecnologia medica specializzata nel monitoraggio ECG, ha annunciato alternative per l'accesso ai materiali della sua Assemblea Generale Annuale (AGA) a causa dello sciopero in corso di Canada Post. I materiali della riunione per l'AGA del 11 dicembre 2024 sono disponibili su SEDAR+ e sul sito web dell'azienda.
I soci registrati possono contattare direttamente l'azienda al numero 1-877-977-9425 o tramite email per assistenza con la delega, con una scadenza per il voto fissata alle 11:00 a.m. EST del 9 dicembre 2024. Gli azionisti beneficiari devono contattare i propri broker per richieste di delega. Le copie cartacee dei materiali della riunione possono essere richieste fino al 6 dicembre 2024.
CardioComm Solutions (TSXV: EKG, OTC: EKGGF), una empresa de tecnología médica especializada en el monitoreo de ECG, ha anunciado alternativas para acceder a los materiales de su Junta General Anual (JGA) debido a la huelga en curso de Canada Post. Los materiales de la reunión para la JGA del 11 de diciembre de 2024 están disponibles en SEDAR+ y en el sitio web de la empresa.
Los accionistas registrados pueden contactar a la empresa directamente al 1-877-977-9425 o por correo electrónico para obtener asistencia con la delegación, con una fecha límite de votación establecida a las 11:00 a.m. EST del 9 de diciembre de 2024. Los accionistas beneficiarios deben contactar a sus corredores para solicitudes de delegación. Las copias impresas de los materiales de la reunión pueden ser solicitadas hasta el 6 de diciembre de 2024.
CardioComm Solutions (TSXV: EKG, OTC: EKGGF), 심전도 모니터링 기술 회사가 캐나다 우체국 파업으로 인해 연례 총회(AGM) 자료에 대한 대체 방안을 발표했습니다. 2024년 12월 11일 AGM의 회의 자료는 SEDAR+ 및 회사 웹사이트에서 확인할 수 있습니다.
등록된 주주는 1-877-977-9425로 회사에 직접 연락하거나 이메일을 통해 대리인을 요청할 수 있으며, 투표 마감 시간은 2024년 12월 9일 오전 11시(동부 표준시)로 설정되어 있습니다. 실질 주주는 대리 요청에 대해 자신들의 브로커에게 문의해야 합니다. 회의 자료의 종이 사본은 2024년 12월 6일까지 요청할 수 있습니다.
CardioComm Solutions (TSXV: EKG, OTC: EKGGF), une entreprise de technologie médicale spécialisée dans la surveillance ECG, a annoncé des dispositions alternatives pour accéder aux documents de son Assemblée Générale Annuelle (AGA) en raison de la grève en cours de Canada Post. Les documents de la réunion pour l'AGA du 11 décembre 2024 sont disponibles sur SEDAR+ et le site Web de l'entreprise.
Les actionnaires enregistrés peuvent contacter l'entreprise directement au 1-877-977-9425 ou par email pour obtenir de l'aide concernant la procuration, la date limite de vote étant fixée à 11h00 EST le 9 décembre 2024. Les actionnaires bénéficiaires doivent contacter leurs courtiers pour les demandes de procuration. Des copies papier des documents de la réunion peuvent être demandées jusqu'au 6 décembre 2024.
CardioComm Solutions (TSXV: EKG, OTC: EKGGF), ein Unternehmen für medizinische ECG-Überwachungstechnologie, hat aufgrund des laufenden Streiks bei Canada Post alternative Möglichkeiten zur Einsichtnahme in die Unterlagen zur Jahreshauptversammlung (JHV) bekannt gegeben. Die Versammlungsunterlagen für die JHV am 11. Dezember 2024 sind auf SEDAR+ und der Website des Unternehmens erhältlich.
Registrierte Aktionäre können das Unternehmen direkt unter 1-877-977-9425 oder per E-Mail kontaktieren, um Unterstützung bei der Vollmacht zu erhalten, mit einer Frist für die Stimmabgabe bis 11:00 Uhr EST am 9. Dezember 2024. Begünstigte Aktionäre sollten ihre Broker für Vollmachtsanträge kontaktieren. Gedruckte Kopien der Versammlungsunterlagen können bis zum 6. Dezember 2024 angefordert werden.
- None.
- None.
Toronto, Ontario--(Newsfile Corp. - December 4, 2024) - CardioComm Solutions, (TSXV: EKG) (OTC Pink: EKGGF) a global leader in medical electrocardiogram (ECG) monitoring technology and a pioneer in Remote Patient Monitoring (RPM) solutions, announces that due to the ongoing Canada Post strike (the "Postal Strike"), the information circular and related materials (the "Meeting Materials") for its upcoming Annual General Meeting (the "Meeting") to be held on Wednesday, December 11, 2024, are posted under the Company's profile on www.sedarplus.ca and on the Company's website at https://cardiocommsolutions.com/cardiocomm-annual-general-meeting/. Shareholders of the Company are encouraged to access the Meeting Materials directly through the above-mentioned website. While the Meeting Materials have been mailed in the normal course, due to the Postal Strike, there can be no assurance that they will be delivered prior to the Meeting.
Registered shareholders, shareholders who hold their shares directly in the Company and not through a brokerage account or depository company, may contact the Company at 1-877-977-9425 or email info@cardiocommsolutions.com to receive a proxy and assistance with voting. Proxies completed and signed should be forwarded by the voting deadline at 11:00 a.m. EST, Monday, December 9, 2024.
Beneficial shareholders, shareholders who hold their investment through a brokerage house, depository company or other intermediary, and have not received their information, should contact their broker representative to request a proxy.
If you wish to receive a paper copy of the Meeting materials, please contact the Company at 1-877-977-9425 or email info@cardiocommsolutions.com. In order to receive a paper copy in time to vote before the Meeting, your request should be received by Friday, December 6, 2024.
About CardioComm Solutions
Toronto-based CardioComm Solutions' ("CardioComm" and the "Company") proprietary technologies are used remote patient monitoring (RPM). CardioComm's core products are used for remote recording, viewing, analyzing, reporting and storing of electrocardiograms for diagnosis and management of cardiac patients. CardioComm also became the first company to enter into the direct to consumer, personalized ECG monitoring market. With its suite of medically credible heart monitoring solutions for the medical and consumer markets, CardioComm continues to be a leader in ECG management technologies. CardioComm will be expanding use of its RPM and telemedicine technologies into the sports, health and wellness. Such efforts will facilitate the introduction of new wearable devices such as Smartwatches, chest straps, smart garments and patches that will collect additional monitored bio-signs and multiple ECG leads/channels options (1, 3 and 12 lead). Additionally, CardioComm will expand its HeartCheck™ branded direct to consumer solutions to include other bio-sign monitoring devices compatible with CardioComm's technologies. The Company's goal is to provide patients and caregivers with opportunities to consult and collaborate with specialists no matter the location, improving patient care and reducing costs. CardioComm has earned the ISO 13485 MDSAP and ISO 27001 certifications, is HIPAA compliant and holds medical device clearances and sales licenses from the USA (FDA) and Canada (Health Canada).
FOR FURTHER INFORMATION PLEASE CONTACT:
Etienne Grima, Chief Executive Officer
1-877-977-9425 x227
investor.relations@cardiocommsolutions.com
Forward-looking statements
This release may contain certain forward-looking statements and forward-looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. Such statements and information reflect management's current beliefs and are based on information currently available to management. By their nature, forward-looking statements and forward-looking information involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements and forward-looking information.
In evaluating these statements, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this release other than as required by applicable laws, including without limitation, Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/232541
FAQ
When is CardioComm Solutions (EKGGF) holding its Annual General Meeting in 2024?
How can shareholders access CardioComm Solutions (EKGGF) AGM materials during the Canada Post strike?
What is the voting deadline for CardioComm Solutions (EKGGF) 2024 AGM proxies?
